Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.

The long-term repopulating hematopoietic stem cell (HSC) population can self-renew in vivo, support hematopoiesis for the lifetime of the individual, and is of critical importance in the context of bone marrow stem cell transplantation. The mechanisms that regulate the expansion of HSCs in vivo and...

Full description

Bibliographic Details
Main Authors: Gregory A Bird, Avital Polsky, Patricia Estes, Teri Hanlon, Haley Hamilton, John J Morton, Jonathan Gutman, Antonio Jimeno, Brian C Turner, Yosef Refaeli
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4149411?pdf=render
_version_ 1811321112768806912
author Gregory A Bird
Avital Polsky
Patricia Estes
Teri Hanlon
Haley Hamilton
John J Morton
Jonathan Gutman
Antonio Jimeno
Brian C Turner
Yosef Refaeli
author_facet Gregory A Bird
Avital Polsky
Patricia Estes
Teri Hanlon
Haley Hamilton
John J Morton
Jonathan Gutman
Antonio Jimeno
Brian C Turner
Yosef Refaeli
author_sort Gregory A Bird
collection DOAJ
description The long-term repopulating hematopoietic stem cell (HSC) population can self-renew in vivo, support hematopoiesis for the lifetime of the individual, and is of critical importance in the context of bone marrow stem cell transplantation. The mechanisms that regulate the expansion of HSCs in vivo and in vitro remain unclear to date. Since the current set of surface markers only allow for the identification of a population of cells that is highly enriched for HSC activity, we will refer to the population of cells we expand as Hematopoietic Stem and Progenitor cells (HSPCs). We describe here a novel approach to expand a cytokine-dependent Hematopoietic Stem and Progenitor Cell (HSPC) population ex vivo by culturing primary adult human or murine HSPCs with fusion proteins including the protein transduction domain of the HIV-1 transactivation protein (Tat) and either MYC or Bcl-2. HSPCs obtained from either mouse bone marrow, human cord blood, human G-CSF mobilized peripheral blood, or human bone marrow were expanded an average of 87 fold, 16.6 fold, 13.6 fold, or 10 fold, respectively. The expanded cell populations were able to give rise to different types of colonies in methylcellulose assays in vitro, as well as mature hematopoietic populations in vivo upon transplantation into irradiated mice. Importantly, for both the human and murine case, the ex vivo expanded cells also gave rise to a self-renewing cell population in vivo, following initial transplantation, that was able to support hematopoiesis upon serial transplantation. Our results show that a self-renewing cell population, capable of reconstituting the hematopoietic compartment, expanded ex vivo in the presence of Tat-MYC and Tat-Bcl-2 suggesting that this may be an attractive approach to expand human HSPCs ex vivo for clinical use.
first_indexed 2024-04-13T13:10:58Z
format Article
id doaj.art-ac2ba349a62549488a081728798186cc
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T13:10:58Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ac2ba349a62549488a081728798186cc2022-12-22T02:45:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0198e10552510.1371/journal.pone.0105525Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.Gregory A BirdAvital PolskyPatricia EstesTeri HanlonHaley HamiltonJohn J MortonJonathan GutmanAntonio JimenoBrian C TurnerYosef RefaeliThe long-term repopulating hematopoietic stem cell (HSC) population can self-renew in vivo, support hematopoiesis for the lifetime of the individual, and is of critical importance in the context of bone marrow stem cell transplantation. The mechanisms that regulate the expansion of HSCs in vivo and in vitro remain unclear to date. Since the current set of surface markers only allow for the identification of a population of cells that is highly enriched for HSC activity, we will refer to the population of cells we expand as Hematopoietic Stem and Progenitor cells (HSPCs). We describe here a novel approach to expand a cytokine-dependent Hematopoietic Stem and Progenitor Cell (HSPC) population ex vivo by culturing primary adult human or murine HSPCs with fusion proteins including the protein transduction domain of the HIV-1 transactivation protein (Tat) and either MYC or Bcl-2. HSPCs obtained from either mouse bone marrow, human cord blood, human G-CSF mobilized peripheral blood, or human bone marrow were expanded an average of 87 fold, 16.6 fold, 13.6 fold, or 10 fold, respectively. The expanded cell populations were able to give rise to different types of colonies in methylcellulose assays in vitro, as well as mature hematopoietic populations in vivo upon transplantation into irradiated mice. Importantly, for both the human and murine case, the ex vivo expanded cells also gave rise to a self-renewing cell population in vivo, following initial transplantation, that was able to support hematopoiesis upon serial transplantation. Our results show that a self-renewing cell population, capable of reconstituting the hematopoietic compartment, expanded ex vivo in the presence of Tat-MYC and Tat-Bcl-2 suggesting that this may be an attractive approach to expand human HSPCs ex vivo for clinical use.http://europepmc.org/articles/PMC4149411?pdf=render
spellingShingle Gregory A Bird
Avital Polsky
Patricia Estes
Teri Hanlon
Haley Hamilton
John J Morton
Jonathan Gutman
Antonio Jimeno
Brian C Turner
Yosef Refaeli
Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.
PLoS ONE
title Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.
title_full Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.
title_fullStr Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.
title_full_unstemmed Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.
title_short Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins.
title_sort expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using myc and bcl 2 fusion proteins
url http://europepmc.org/articles/PMC4149411?pdf=render
work_keys_str_mv AT gregoryabird expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins
AT avitalpolsky expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins
AT patriciaestes expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins
AT terihanlon expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins
AT haleyhamilton expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins
AT johnjmorton expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins
AT jonathangutman expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins
AT antoniojimeno expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins
AT briancturner expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins
AT yosefrefaeli expansionofhumanandmurinehematopoieticstemandprogenitorcellsexvivowithoutgeneticmodificationusingmycandbcl2fusionproteins